Complete Story
06/01/2022
OSOMS Updates and News You Can Use
Did you know OSOMS lists career opportunities and classifieds?
An associate leading to early partnership opportunity is now posted for the NE Ohio area. Check it out!
Save the Date: March 30 - April 2, 2023
OSOMS Annual Meeting - Nationwide Conference Center, Lewis Center
An important component of the OMS Quality Outcomes Registry (OMSQOR®) is the Dental Anesthesia Incident Reporting System (DAIRS).
DAIRS is an anonymous self-reporting system used to collect and analyze anesthesia incidents in order to improve the quality of dental anesthesia care. All dental anesthesia providers are encouraged to report any unintended event related to the delivery of anesthesia for a dental patient. Some examples of anesthesia incidents to be reported may include:
- Laryngospasm
- Cardiac event
- Equipment failure
- Drug interaction
- Serious incidents that cause permanent harm
Reporting is anonymous. All reports to DAIRS are maintained as privileged and confidential in the DAIRS module of the OMSQOR system. Reported cases may be selected for educational presentation but will not include any identifiable patient or provider information.
For more information on DAIRS, email dairs@aaoms.org
Members encouraged to take opioid survey
AAOMS is interested in learning about our members’ evolving prescribing habits. We are asking you to participate in our fourth member survey on opioid prescribing patterns – and the first since 2019. The 2022 AAOMS Opioid Prescribing Survey is available here. The deadline to complete the online survey is June 22.
AAOMS hopes to utilize OMS prescribing trends to aid our advocacy efforts. We believe the results will demonstrate to legislators and regulators that our members remain aware of the ongoing opioid abuse epidemic and continue to take steps to decrease the number of drugs prescribed.
We thank you for your participation.
Register for upcoming anesthesia training modules
Three sessions of the AAOMS National Simulation Training Program’s Office-Based Emergency Airway Management (OBEAM) module will be held in the coming months at the OMS Institute for Education and Innovation in Rosemont, Ill. Members can sign up for four hours of advanced simulation training of anesthesia techniques through intensive, real-life experiences. Offerings include:
- June 5 from 1 to 5 p.m. CDT
- Aug. 6 from 8 a.m. to noon or 1 to 5 p.m. CDT
To register online or for more information, visit AAOMS.org/OBEAM.
OMS Foundation accepting GIVE applications
The Foundation is accepting applications from both OMS residents and humanitarian healthcare programs for GIVE (Global Initiative for Volunteerism and Education). Three OMS residents have traveled to Bangladesh and the Philippines with approved programs in 2022, thanks to GIVE awards.
GIVE is supported by Canfield, Inc., OMSNIC and by OMS Foundation Alliance events such as the Luncheon and FUNraiser and Daily Health Walks during the Annual Meeting. Even those unable to attend in New Orleans can take part with a Virtual Health Walk.
Learn more about GIVE and donate today.
Over the past few years, studies have shown a global rise in oropharyngeal cancer, (OPC). The increase in OPC incidence has been attributed to Human Papillomavirus (HPV) infection. HPV has been shown by the CDC to be one of the most common sexually transmitted infections in the United States. Since OPC is the most common cancer caused by HPV, the specialty of oral and maxillofacial surgery has a unique opportunity to contribute to the prevention of this cancer which is ubiquitous in our region of purview. Every one of us sometime during our career can remember a patient who has consulted for the removal of wisdom teeth or other dento-alveolar procedure only to be surprised and mortified to find a lesion in their mouth that turns out to be cancer of HPV origin. The specialty of oral and maxillofacial surgery has an opportunity to contribute the prevention of HPV – related oral cancer by discussing and encouraging the HPV vaccine with their patients. What is our profession’s contribution ,this very day, to the education of our patents concerning oral cancer, HPV and the vaccine available to help prevent it? The answer remains opaque.
That is why the Minnesota Department of Head and Neck Surgery, the University of Miami and Delta Dental of Minnesota are in the process of conducting a study to evaluate the practice patterns of Oral and Maxillofacial surgeons regarding Head and Neck Cancer surveillance and HPV vaccinations.
The study is titled “A Survey to Assess Maxillofacial Surgeons Perspective on Human Papillomavirus Counseling and Vaccination”. This study is survey based and is being sent to several State Societies including Ohio. The study is being conducted by Deepak Kademani , DMD, MD, and Hamad Alharbi, DDS at the University of Minnesota and Arshad Kaleem DMD, MD, and Ramzey Tursun, DDS, at the University of Miami. Corporate assistance is headed by Eileen Crespo, MD of Minnesota Delta Dental.
We are privileged to participate in this study along with State Societies from Oregon, Florida, Tennessee, Texas, California and Illinois, just to name a few at the time of this correspondence.
This survey is anonymous. You will be asked to complete an electronic survey. The survey should take only 3-5 minutes to complete. No one will be able to identify you or your answers, and no one will know whether you participated in the study.
You may open the survey in your web browser by clicking the link below:
If you have any questions or concerns about completing the questionnaire or about participating in this study, you may contact us at the Ohio Society or survey sponsor, Hamad Alharbi at: Harbi.hamad@gmail.com
